Evidence map›Paper›PMID 42074058›Full record

ArticleInternational journal of molecular sciences2026

Bronchial and Systemic Relationships of

Eduard Monsó, Carme Casadevall, Sara Quero, Sergi Pascual-Guàrdia, César Jésse Enríquez-Rodríguez, Laura Millares, Concepción Montón, Rosa Faner, Silvia Capilla, Luis Miguel Seijo and 7 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Eduard MonsóInstitut d' Investigació i Innovació Parc Taulí (I3PT-CERCA), 08208 Sabadell, Spain.
Carme CasadevallBarcelona Respiratory Network, 08009 Barcelona, Spain.ORCID 0000-0001-6458-8972
Sara QueroInstitut d' Investigació i Innovació Parc Taulí (I3PT-CERCA), 08208 Sabadell, Spain.
Sergi Pascual-GuàrdiaBarcelona Respiratory Network, 08009 Barcelona, Spain.ORCID 0000-0002-6567-0916
César Jésse Enríquez-RodríguezBarcelona Respiratory Network, 08009 Barcelona, Spain.ORCID 0000-0002-5944-6555
Laura MillaresInstitut d' Investigació i Innovació Parc Taulí (I3PT-CERCA), 08208 Sabadell, Spain.
Concepción MontónDepartment of Respiratory Medicine, Hospital Universitari Parc Taulí, Universitat Autònoma de Barcelona, 08208 Sabadell, Spain.
Rosa FanerBarcelona Respiratory Network, 08009 Barcelona, Spain.ORCID 0000-0002-8159-0115
Silvia CapillaDepartment of Microbiology, Hospital Universitari Parc Taulí, Universitat Autònoma de Barcelona, 08208 Sabadell, Spain.
Luis Miguel SeijoCentro de Investigación Biomédica en Red, Área de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Ady Castro-AcostaCentro de Investigación Biomédica en Red, Área de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Carlos Alvarez-MartínezCentro de Investigación Biomédica en Red, Área de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-1343-3847
Oriol SibilaBarcelona Respiratory Network, 08009 Barcelona, Spain.
Germán Peces-BarbaCentro de Investigación Biomédica en Red, Área de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Borja G CosioCentro de Investigación Biomédica en Red, Área de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Alvar AgustíBarcelona Respiratory Network, 08009 Barcelona, Spain.
Joaquim GeaBarcelona Respiratory Network, 08009 Barcelona, Spain.

Funding

Fondo de Investigación Sanitaria, Instituto de Salud Carlos III; FEDER Ministerio de Economía y Competitividad; Fundació Pla Armengol; Centro de Investigación Biomédica en Red Area de Enfermedades Respiratorias (CIBERES) - CIBERES is an initiative of the PI15/00167, PI15/02042, PI18/00934, SAF 2014-54371
6 · The paper itself

Abstract

The aim of the study was to assess the microbial composition of bronchial secretions in chronic obstructive pulmonary disease (COPD), focusing on the impact of the exacerbation patterns on the common components of the respiratory flora and their relationship with inflammatory proteins. A total of 72 clinically stable COPD patients provided sputum and blood samples for 16S rRNA gene amplification and peripheral biomarkers. Beta-diversity analyses of the bronchial microbiome showed significant differences between infrequent and frequent (≥2) exacerbators (

Indexed as

BronchiHaemophilusHaemophilus InfectionsPulmonary Disease, Chronic ObstructiveAgedBiomarkersFemaleHaemophilus influenzaeHumansMaleMicrobiotaMiddle AgedRNA, Ribosomal, 16SSputumBiomarkersRNA, Ribosomal, 16SadmissionCOPDexacerbationHaemophilus influenzaeHaemophilus parainfluenzaeinterleukin-8microbiome

Identifiers

PMID42074058
PMCPMC13115855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.